These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 14234364)

  • 21. EPSILON-AMINOCAPROIC ACID (EACA).
    NAHUM LH
    Conn Med; 1964 Sep; 28():641-5. PubMed ID: 14201313
    [No Abstract]   [Full Text] [Related]  

  • 22. EXPERIMENTAL VENOUS THROMBOSIS IN RATS. INCREASED FORMATION DURING INHIBITION OF THE FIBRINOLYTIC SYSTEM WITH EPSILON AMINO CAPROIC ACID.
    NORDOEY A
    Thromb Diath Haemorrh; 1963 Jul; 143():427-35. PubMed ID: 14081264
    [No Abstract]   [Full Text] [Related]  

  • 23. [FIBRINOLYSIS; CLINICAL APPLICATIONS].
    BOSMAN G
    Folia Med Neerl; 1964 Dec; 7():178-83. PubMed ID: 14265806
    [No Abstract]   [Full Text] [Related]  

  • 24. [DISSOCIATED EFFECTS OF A NEW ANTIFIBRINOLYTIC AGENT (EPSILON-AMINOCAPROIC ACID) INJECTED "IN VIVO", ON "IN VITRO" FIBRINOLYSIS TESTS].
    WEISS M; YVER J; SAMAMA M; DUBOST C
    Presse Med (1893); 1963 Sep; 71():1879-80. PubMed ID: 14091607
    [No Abstract]   [Full Text] [Related]  

  • 25. ANTI-FIBRINOLYTIC EFFECT OF EPSILON-AMINOCAPROIC ACID AS MEASURED BY IN VIVO CLOT LYSIS.
    MUTSCHLER LE
    Proc Soc Exp Biol Med; 1964 Apr; 115():1019-24. PubMed ID: 14166549
    [No Abstract]   [Full Text] [Related]  

  • 26. [THE EFFECT OF EPSILON-AMINOCAPROIC ACID (EACA) ON BLOOD COAGULATION TIME].
    GAERTNER H; LISIEWICZ J; SIEROSLAWSKI H; SZIRMAI E
    Acta Med Okayama (1952); 1963 Jun; 17():123-6. PubMed ID: 14121937
    [No Abstract]   [Full Text] [Related]  

  • 27. [APROPOS OF A COMPLEX HEMORRHAGIC SYNDROME TREATED WITH EPSILON-AMINOCAPROIC ACID].
    CROIZAT P; REVOL L; THOUVEREZ ; BELLEVILLE ; BRUNAT
    Lyon Med; 1964 Feb; 211():403-9. PubMed ID: 14141971
    [No Abstract]   [Full Text] [Related]  

  • 28. [BLOOD COAGULATION DISORDERS DURING LABOR WITH SPECIAL REFERENCE TO FIBRINOLYSIS].
    OPPELT HG; BECK L
    Geburtshilfe Frauenheilkd; 1965 Jan; 25():46-55. PubMed ID: 14262686
    [No Abstract]   [Full Text] [Related]  

  • 29. 2 CASES OF FIBRINOLYSIS DURING SHUNT OPERATION IN CIRRHOSIS OF THE LIVER.
    LEIBA H; RAMOT B; MANY A
    Isr Med J; 1964; 23():176-80. PubMed ID: 14215370
    [No Abstract]   [Full Text] [Related]  

  • 30. [ON THE MODE OF ACTION OF EPSILON-AMINOCAPROIC ACID].
    RITZEL G; WUETHRICH R
    Schweiz Med Wochenschr; 1964 Feb; 94():267-71. PubMed ID: 14153727
    [No Abstract]   [Full Text] [Related]  

  • 31. [FIBRINOLYSIS IN UROLOGIC PATIENTS].
    VELIKANOV KA
    Urol Mosc; 1964; 29():57-66. PubMed ID: 14185380
    [No Abstract]   [Full Text] [Related]  

  • 32. [ON THE ANTI-FIBRINOLYTIC EFFECT OF DERIVATIVES OF P-AMINOMETHYLBENZOID ACID (PAMBA)].
    MARKWARDT F; RICHTER M
    Acta Biol Med Ger; 1964; 13():719-24. PubMed ID: 14308701
    [No Abstract]   [Full Text] [Related]  

  • 33. [EFFECT OF EPSILON-AMINOCAPROIC ACID ON EXPERIMENTAL PANCREATITIS IN RATS].
    DIWOK K; GUELZOW M; TRETTIN HJ
    Z Gesamte Inn Med; 1965 Feb; 20():111-2. PubMed ID: 14264674
    [No Abstract]   [Full Text] [Related]  

  • 34. METHOD FOR DETERMINING EPSILON-AMINOCAPROIC ACID (EACA) IN BLOOD PLASMA, BASED ON THE ANTIFIBRINOLYTIC PROPERTIES OF THIS COMPOUND.
    WOLOSOWICZ N; NIEWIAROWSKI S; CZEREPKO K
    Thromb Diath Haemorrh; 1964 Jan; 10():309-16. PubMed ID: 14113373
    [No Abstract]   [Full Text] [Related]  

  • 35. [PREVENTION AND TREATMENT OF FIBRINOLYTIC HYPERACTIVITY IN UROLOGIC SURGERY].
    CUOCOLO R; DESANTIS S; SPAMPINATO N; GUIDONE M
    Rass Int Clin Ter; 1965 May; 45():468-80. PubMed ID: 14343408
    [No Abstract]   [Full Text] [Related]  

  • 36. Successful treatment of skeletal hemangioma and Kasabach-Merritt syndrome with aminocaproic acid. Is fibrinolysis "defensive"?
    Neidhart JA; Roach RW
    Am J Med; 1982 Sep; 73(3):434-8. PubMed ID: 7124770
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [A NEW METHOD OF THE ANALYSIS OF EPSILON-AMINOCAPROIC ACID (EACA) AND AMINOMETHYLCYCLOHEXANE CARBOXYLIC ACID (AMCHA), THE POTENT ANTIFIBRINOLYTIC AGENTS].
    TAKATA Y; TAKATA A; OKAMOTO U
    Nihon Seirigaku Zasshi; 1964 May; 26():281-5. PubMed ID: 14172890
    [No Abstract]   [Full Text] [Related]  

  • 38. [PROSTATIC TISSUE AND FIBRINOLYTIC-PROTEOLYTIC ACTIVITY].
    FUERSTENBERG HS
    Urol Int; 1965; 19():326-31. PubMed ID: 14316550
    [No Abstract]   [Full Text] [Related]  

  • 39. [ATTEMPT AT TREATMENT OF 3 CASES OF SCLERODERMA WITH EPSILON-AMINOCAPROIC ACID].
    LAUGIER P; RISOLD JC
    Bull Soc Fr Dermatol Syphiligr; 1964; 71():645-6. PubMed ID: 14266365
    [No Abstract]   [Full Text] [Related]  

  • 40. EFFECTS OF EPSILON AMINO CAPROIC ACID (EACA) ON SURVIVAL OF FIBRINOGEN I-131 AND ON FIBRINOLYTIC AND COAGULATION FACTORS IN DOGS.
    LEWIS JH
    Proc Soc Exp Biol Med; 1963 Dec; 114():777-8. PubMed ID: 14120347
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.